Ally Therapeutics
Cambridge, US · Founded 2018 · Delaware corporation · 2 known investors
Founders & leadership
TL
Tina LiuNamed on SEC filing
DC
David CordoNamed on SEC filing
EW
Erica WhittakerNamed on SEC filing
SG
Steve GillisNamed on SEC filing
Board
Investors · 2
Reported raises · per SEC filings
Form D private placements$10M disclosed across 1 round · 2019
▶$10MraisedAug 2019 · 3 investors · PharmaceuticalsRule 506(b)
▶$10MraisedAug 2019 · 3 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Tina LiuExecutive Officer, Director
- David CordoExecutive Officer
- Bob MoreDirector
- Erica WhittakerDirector
- Steve GillisDirector
- Offering amount
- $11M
- Amount sold
- $10M
- First sale
- Jul 2019
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who are Ally Therapeutics's investors?
- Ally Therapeutics's investors include Alta Partners, ARCH Venture Partners.
- How much funding has Ally Therapeutics raised?
- Ally Therapeutics has disclosed $10M raised across 1 round.
- Where is Ally Therapeutics headquartered?
- Ally Therapeutics is headquartered in Cambridge, US.